Siemens (NYSE:SI) Healthineers said today it won FDA clearance for its Magnetom Vida 3 Tesla magnetic resonance imaging system.
The company said that the newly cleared 3T MRI scanner features new BioMatrix technology designed to address inherent anatomical and physiological differences in patients and user variability to reduce rescans and increase productivity and cost efficiency.
Siemens said that the Magnetom Vida features BioMatrix sensors built into the patient table to automatically track respiratory patterns to improve exam strategies. The device’s BioMatrix tuners help improve the quality and reproducibility of whole-spine diffusion imaging through individual slice adjustments designed to mitigate distortion.
The system also includes improvements which improve energy efficiency to lower ownership cost overtime, with intelligent control over power-demanding components to deactivate them when they are inactive for long periods.
“With the Magnetom Vida, Siemens Healthineers proudly offers customers a 3T MRI system that provides unprecedented levels of personalization throughout the patient examination, to effectively address the unique challenges of each patient group and provide high-quality imaging to previously underserved segments of the population,” Siemens Healthineers NA magnetic resonance VP Murat Gungo said in a press release.
Earlier this month, Siemens Healthineers said it launched its Symbia Intevo Bold CT and single-photon emission computed tomography system.
The company touted the device as addressing the growing use of SPECT/CT systems in a dual-use setting, and said that such devices can increase efficiency for SPECT patients who also require diagnostic CT scans through acquiring both sets of images through the same system.